Disrupting the balance between self-renewal and differentiation of hematopoietic stem cells (HSCs) leads to bone marrow failure or hematologic malignancy. However, how HSCs sustain their quiescent state and avoid type I interferon (IFN)-mediated exhaustion remains elusive. Here we defined a circular RNA that we named cia-cGAS that was highly expressed in the nucleus of long-term (LT)-HSCs. CiacGAS deficiency in mice caused elevated expression of type I IFNs in bone marrow and led to decreased numbers of dormant LT-HSCs. Under homeostatic conditions, cia-cGAS bound DNA sensor cGAS in the nucleus to block its synthase activity, thereby protecting dormant LT-HSCs from cGAS-mediated exhaustion. Moreover, cia-cGAS harbored a stronger binding affinity to cGAS than self-DNA did and consequently suppressed cGAS-mediated production of type I IFNs in LT-HSCs. Our findings reveal a mechanism by which cia-cGAS inhibits nuclear cGAS by blocking its enzymatic activity and preventing cGAS from recognizing self-DNA to maintain host homeostasis.
In Brief
Disrupting the balance between selfrenewal and differentiation of HSCs leads to severe pathologic consequences. Xia et al. identify a circular RNA cia-cGAS that is highly expressed in the nucleus of LTHSCs. Under homeostatic conditions, cia-cGAS binds DNA sensor cGAS to block its synthase activity, protecting dormant LT-HSCs from cGAS-mediated exhaustion.
INTRODUCTION
Hematopoietic stem cells (HSCs) residing in the bone marrow (BM) are a limited pool of immature progenitors, acting as the architects of definitive hematopoiesis throughout the life of an organism (Ivanova et al., 2002) . Long-term HSCs (LT-HSCs), the very top of the cellular hierarchy, possess their potential to self-renew and differentiate for continuous supply of blood cells (Rossi et al., 2012) . Downstream of LT-HSCs are reservoirs of stem and progenitor cells with diminished self-renewal potential: the short-term HSCs (ST-HSCs), multipotent progenitors (MPPs), as well as the lineage-restricted progenitors. In a resting state, most of HSCs are in a dormant state that sustains a reservoir of HSC cells. Therefore, the HSC stemness is tightly modulated via intrinsic factors such as transcription factors as well as extrinsic factors of BM niches (Riddell et al., 2014; Wilson et al., 2008; Zhou et al., 2016) . For instance, tumor necrosis factor (TNF) restricts HSC self-renewal capacity through two TNF receptors-mediated signaling (Pronk et al., 2011) . Chemokine CXCL4 secreted by megakaryocytes of BM can sustain HSC quiescence (Bruns et al., 2014) . Moreover, persistent induction of type I interferons (IFNs) drives HSCs into cycling via the interferon (IFN-a/b) receptor (IFNAR)-mediated signaling activation leading to HSC exhaustion (Essers et al., 2009; Sato et al., 2009 ). However, how HSCs maintain the balance of their quiescence and cycling still remains elusive.
Cyclic GMP-AMP (cGAMP) synthase (cGAS) has been defined as a cytosolic DNA sensor (Gao et al., 2013a; Li et al., 2013b; Sun et al., 2013) . Upon binding DNA, cGAS catalyzes the synthesis of cGAMP product, which in turn interacts with and activates the adaptor STING molecule and then elicits production of type I IFNs (Chen et al., 2016; Hornung et al., 2014; Xia et al., 2016a ). cGAS recognizes a wide variety of pathogenic DNAs, including DNA viruses, certain retroviruses, and even intracellular bacteria (Schoggins et al., 2014; Wassermann et al., 2015; Yoh et al., 2015) . Moreover, cGAS is also able to monitor self-originated DNA (Rongvaux et al., 2014; White et al., 2014) , which mediates cGAS-STING-dependent type I IFN production. In addition, cGAS can also strongly bind double-stranded RNA (dsRNA) (Civril et al., 2013) , which does not initiate the activation of cGAS. Apart from the cytoplasm, cGAS also localizes to the nucleus . However, how nuclear cGAS is prevented from detecting self DNA to avoid host injury in a steady state is unknown.
Circular RNAs (circRNAs), a class of non-coding RNAs, are characterized with a covalent bond linking the 3 0 and 5 0 ends generated by backsplicing (Chen, 2016) . Most, if not all, circRNAs are byproducts of RNA splicing, a process mediated by spliceosomes or by group I and group II ribozymes (Vicens and Westhof, 2014) . circRNAs comprise exons, introns, or even exon-introns Zhang et al., 2013 Zhang et al., , 2014 . circRNAs are broadly expressed in a tissue and developmentstage-specific pattern and a subset of circRNAs exhibits conservation across species (Conn et al., 2015; Memczak et al., 2013; Salzman et al., 2013) . Two circRNAs, ciRS-7/CDR1as and Sry circRNA, have been characterized as miRNA sponges (C) Northern blotting of circRNAs from LT-HSC RNAs treated with or without RNase R using head-to-tail probes. GAPDH served as a positive control using intergenic probes. Total RNAs without RNase R treatment served as loading controls.
(D and E) Wild-type (WT) LT-HSCs were infected with lentiviruses carrying shRNAs against circRNAs for 36 hr, followed by viable cell separation through 7-AAD staining. Two pairs of shRNAs were used for each circRNA. 10 2 infected LT-HSCs were transplanted with 3 3 10 5 WT CD45.1 BM cells into lethally irradiated
CD45.1 mice (D). 16 weeks later, LT-HSCs were isolated from engrafted mice for knockdown efficiency examination by RT-PCR (E).
(F and G) LT-HSCs were infected with lentiviruses carrying control or shcia-cGAS shRNAs for 36 hr, followed by 7-AAD staining of dead cells before transplantation. Cell numbers of LSKs (F) and LT-HSCs (G) in BM of shcircRNA LT-HSCs reconstituted mice were examined through flow cytometry. n = 8 for (D)-(G).
(H) Northern blotting analysis of cia-cGAS expression in various mouse organs and tissues using head-to-tail probes against cia-cGAS. (I) cDNAs from mouse LT-HSCs, human umbilical cord blood LT-HSCs, and rat LT-HSCs were used as templates to amplify cia-cGAS using divergent primers.
(J) Expression levels of cia-cGAS in the indicated cells from BM or periphery were examined by RT-PCR. Equal numbers of indicated cells were subjected to RNA extraction and RT-PCR analysis. Expression levels of cia-cGAS were normalized to that of MPP cells. (Hansen et al., 2013; Memczak et al., 2013) . It has been reported that exon-intronic circRNAs mainly reside in the nucleus and associate with RNA polymerase II to regulate the transcription of their parental genes . A recent report showed that fusion circRNAs generated from cancer-associated chromosomal translocations are implicated in tumorigenesis and resistance upon therapy (Guarnerio et al., 2016) . Here we defined a circular RNA originated from D430042O09Rik gene transcripts that we named cia-cGAS (circular RNA antagonist for cGAS), which was highly constitutively expressed in the nucleus of LTHSCs. Under normal conditions, cia-cGAS bound nuclear cGAS to block its enzymatic activity and protected dormant LT-HSCs from cGAS-mediated exhaustion.
RESULTS
Circular RNA Cia-cGAS Is Highly Expressed in the Nucleus of LT-HSCs To explore how circRNAs impacted self-renewal of HSCs, we isolated long-term HSCs (LT-HSCs) and multipotent progenitor cells (MPPs) from mouse bone marrow (BM) ( Figure S1A ) and performed transcriptome gene expression profiles for these two subsets. Through bioinformatic analysis, we identified 49 upregulated and 107 downregulated circRNAs in LT-HSCs in contrast to those of MPPs ( Figure 1A ). We further examined the expression profiles of these upregulated circRNAs in three LSK (Lin
À

Sca1
+ cKit + ) progenitor subsets including LT-HSCs, short-term (ST)-HSCs, and MPPs. We found that only nine circRNAs were highly expressed in LT-HSCs ( Figure 1B ). Elevated mRNA expression of these nine circRNAs in LT-HSCs was further validated by RT-PCR ( Figure S1B ). mRNAs of their respective parental linear genes against these circRNAs were also accumulated in LT-HSCs ( Figure S1B ). All the nine circRNAs in mouse LT-HSCs were further verified and shared the same compositions as previously reported sequences from the mouse brain (Figures 1C and S1C-S1E; Memczak et al., 2013) . To test the roles of these nine circRNAs in HSCs, we first isolated wild-type (WT) LT-HSCs from BM and silenced these circRNAs with shRNAs targeting head-to-tail regions in LT-HSCs and then transplanted these cells to lethally irradiated CD45.1 recipient mice ( Figure 1D ). Silencing efficiencies of these nine circRNAs were all more than 80% in CD45.2 LT-HSCs (Figure 1E ). Among these nine circRNAs, only knockdown of ciacGAS caused higher numbers of immature progenitor LSK cells and lower numbers of LT-HSCs in BM as well as reduced BM cellularity compared to scrambled RNA (shCtrl)-treated cells ( Figures 1F, 1G , and S1F). By contrast, knockdowns of other eight circRNAs had no significant impact on the repopulation establishment of LT-HSCs ( Figures 1F, 1G , and S1F). Similar results were obtained with second respective pairs of shRNAs ( Figures S1G-S1J ). These data suggest that cia-cGAS is involved in the regulation of HSC self-renewal.
We found that the linear RNAs were not affected when their corresponding circular RNAs were knocked down (Figures S2A and S2B) . We then generated probes specific for cia-cGAS and its parental gene D430042O09Rik. We observed that linear RNA of D430042O09Rik was mainly localized in the cytoplasm of LT-HSCs, whereas cia-cGAS resided in the nucleus ( Figures  S2C and S2D) . To test the role of D430042O09Rik in hematopoiesis, we further knocked down D430042O09Rik expression by shRNAs specific for its linear RNA or both for the linear and circular RNA ( Figure S2E ). We found that knockdown of D430042O09Rik with primers specific for the linear RNA did not affect cell numbers of LT-HSCs or LSKs in the BM ( Figures  S2F-S2H ). However, knockdown of both D430042O09Rik and cia-cGAS with primers against the linear and circular RNA caused increased LSK cells and decreased LT-HSCs ( Figures  S2I-S2K ). These results indicate that knockdown of cia-cGAS does not impact the expression level of linear RNA and that cia-cGAS knockdown is likely responsible for the phenotype caused by cia-cGAS depletion.
We next examined the expression profile of cia-cGAS in different mouse tissues. We observed that cia-cGAS was most highly expressed in HSCs among the tissues we tested (Figure 1H) . It was also expressed in liver, brain, testis, and other tissues ( Figure 1H ). Moreover, cia-cGAS was highly conserved in different species ( Figure 1I ). Of hematopoietic progenitors and mature blood cells we tested, cia-cGAS was highly expressed in LT-HSCs ( Figure 1J ) and located in the nucleus of LT-HSCs ( Figures 1K and 1L ). These data suggest that circular RNA cia-cGAS is highly expressed in the nucleus of LT-HSCs and involved in the maintenance of HSCs.
Cia-cGAS Deficiency Leads to Dramatic Decrease of Dormant LT-HSCs in Bone Marrow
We next generated cia-cGAS-deficient mice by deleting the downstream reverse complementary sequence of D430042O09Rik (chr7: 125776974-125784712), which was identified by a minigene assay-based circRNA biogenesis (Figures 2A, S3A, and S3B) . Cia-cGAS was completely deleted in cia-cGAS-deficient mice ( Figures 2B and 2C ). As expected, cia-cGAS-deficient mice had much higher numbers of LSK cells and much lower numbers of LT-HSCs compared to WT mice (Figures 2D-2F ). Consequently, cia-cGAS -/-mice displayed reduced BM cellularity and decreased numbers of mature hematopoietic cells in the BM (Figures 2G and 2H ). About 40% of cia-cGAS-deficient mice died of severe anemia at birth of 6 months ( Figure S3C ). Finally, we observed that dead LT-HSCs were increased (Figure S3D ) and manifested reduced BMNC (bone marrow nucleated cell) numbers as well as decreased peripheral blood cells at this time point (Figures S3E and S3F) , suggesting that ciacGAS deletion may cause BM failure. Notably, cia-cGAS deficiency did not apparently affect the expression of its parental gene D430042O09Rik ( Figure S3G ).
cia-cGAS -/-LT-HSCs incorporated more BrdU than ciacGAS +/+ LT-HSCs ( Figure 2I ), and most of cia-cGAS -/-LTHSCs consequently exited G o stage to enter an active cycling state ( Figure 2J ). Nuclear H2B is diluted by cell division and its (K) In situ hybridization of cia-cGAS in LT-HSCs using head-to-tail probes. RNA probes were in green. Nuclei were counterstained with PI. Scale bar, 5 mm.
(L) LT-HSCs were subjected to nuclear and cytoplasmic separation, followed by RNA extraction and RT-PCR analysis of cia-cGAS. Data are shown as means ± SD. Data are representative of at least three independent experiments. See also Figures S1 and S2.
labeling can be used to monitor cell cycling status. To further trace the proliferative history of LT-HSCs, we then generated cia-cGAS-deficient mice with H2B-GFP-expressing HSCs by crossing cia-cGAS -/-mice with Scl-tTA:H2B-GFP reporter mice that labeled quiescent cells with H2B-GFP post doxycycline administration ( Figure S3H ). After administration of doxycycline, cia-cGAS -/-mice exhibited fewer GFP-positive cells than cia-cGAS +/+ mice ( Figure S3I ). Altogether, we conclude that cia-cGAS is required for the maintenance of dormant LT-HSC pool in BM. To further validate the effect of cia-cGAS on quiescent LTHSCs, we transferred cia-cGAS -/-BM cells into lethally irradiated CD45.1 recipient mice for a non-competitive repopulation. We observed that cell numbers of both LSKs and LT-HSCs declined in cia-cGAS -/-BM cell reconstituted mice ( Figure S3J ).
BM cellularity was consistently reduced in cia-cGAS -/-BM cell reconstituted mice compared to that of cia-cGAS +/+ BM cell reconstituted mice ( Figure S3K ). Taken together, cia-cGAS plays a critical role in the maintenance of quiescent HSCs.
Cia-cGAS Deletion Causes Elevated Type I IFNs in LT-HSCs
To determine how cia-cGAS regulated quiescent LT-HSCs, we conducted transcriptome gene expression analysis of gene expression profiles of cia-cGAS +/+ and cia-cGAS -/-LT-HSCs.
We noticed that the IFN-a response genes were highly expressed in cia-cGAS -/-LT-HSCs ( Figure 3A ). Given that type I IFNs activate quiescent HSCs and drive their exhaustion (Essers et al., 2009; Sato et al., 2009) Figure 3I ), while LT-HSC numbers were decreased. However, with Ifnar1 deletion, LSKs and LT-HSCs from cia-cGAS -/-CD45.2 cells were restored to similar numbers compared to WT control mice ( Figure 3I ) and LT-HSCs returned to a resting state. Finally, LT-HSCs but not non-LT-HSCs in the bone marrow produced type I IFNs after cia-cGAS deletion (Figure S4M) , suggesting that LT-HSCs were the major contributor to elevated levels of type I IFNs in cia-cGAS-deficient BM. Altogether, we conclude that cia-cGAS regulates dormant HSCs via type I IFN signaling.
Cia-cGAS Binds to cGAS
To elucidate the molecular mechanism by which cia-cGAS blocked production of type I IFNs in LT-HSCs, we performed an RNA pulldown assay using linearized cia-cGAS RNA to search for potential cia-cGAS-associated proteins. A major differential band precipitated in LSK lysates was identified to be cGAS through mass spectrometry (Figures 4A and S5A) . The interaction between linearized cia-cGAS and cGAS was further validated through probing the precipitates immunoprecipitated by anti-cGAS antibody ( Figure 4B ) and RIP analysis ( Figure 4C ). Whereas anti-cGAS antibody did not precipitate other eight circRNAs ( Figure 4C ). We observed that cGAS mainly distributed in the nucleus of LT-HSCs ( Figures 4D and 4E ). In addition, the cellular localization of cGAS was not affected by cia-cGAS deletion ( Figures S5B and S5C ). Furthermore, cia-cGAS co-localized well with cGAS in the nucleus of LT-HSCs ( Figure 4F ). Deletion of cia-cGAS or cGAS lost their staining signals ( Figure S5D ), validating the specificity of staining signals. These data suggest that cia-cGAS associates with cGAS in the nucleus of LT-HSCs. Besides binding to DNA, cGAS is also able to bind dsRNA (Civril et al., 2013) . To examine whether cGAS needed to associate with cia-cGAS via its double-strand RNA elements, we predicted the secondary structure of linearized cia-cGAS through web servers (Gruber et al., 2008) . Cia-cGAS possessed a double-strand stem region (nt52-104 versus nt149-197) ( Figure S5E ). We then deleted these stem regions in cia-cGAS or substituted this paired region and tested for binding to cGAS in EMSA assays ( Figure 4G ). We found that cGAS associated with full-length ciacGAS, but not with cia-cGAS RNAs lacking either part of the stem regions or with the substitution ( Figure 4H ). These observations were further confirmed through an amplified luminescent-proximity homogeneous assay ( Figure 4I ). In addition, we generated the mutant cGAS with point mutations on the two DNA binding domains (Li et al., 2013a) . The mutant cGAS did not bind to ciacGAS ( Figures 4J and 4K ), whereas the full-length cGAS did.
The cia-cGAS parental gene D430042O09Rik did not interact with cGAS ( Figure S5F ). We then constructed circular RNA expression vectors with the hairpin region of cia-cGAS together with several circular RNAs. We found that hairpins fusing other circular RNAs failed to associate with cGAS ( Figure S5G ). Only full-length cia-cGAS could bind to cGAS ( Figure S5G ). We then transfected these circular RNA expression vectors into cia-cGAS À/À LT-HSCs via lentiviruses, followed by detection of Ifna mRNA expression. We observed that overexpression of the hairpins fusing other circular RNAs could not reduce the elevated Ifna mRNA expression caused by cia-cGAS deficiency (B) LT-HSCs were sorted from cia-cGAS +/+ and cia-cGAS -/-mice, followed by RT-PCR analysis. n = 3 for each.
(C) Type I IFN protein levels were determined by ELISA in BM of cia-cGAS +/+ and cia-cGAS -/-mice. n = 4 for each.
(D) 10 2 cia-cGAS +/+ or cia-cGAS -/-LT-HSCs were co-transplanted with 3 3 10 5 CD45.1 BM cells into lethally irradiated CD45.1 mice, followed by flow cytometry examination of BM cells 16 weeks later. CD45.1-positive cells in the Lin -and IL-7Ra -populations were gated out (left) for LSK analysis (right).
(E) Cell numbers of the indicated populations in BM of cia-cGAS +/+ and cia-cGAS -/-LT-HSC reconstituted mice were calculated.
For (D) and (E), cia-cGAS
(F and G) BM cells from mice with deficiencies in either Ifnar1 or cia-cGAS or both were examined through flow cytometry analysis (F) and cell numbers of the indicated populations in BM of the indicated mice were calculated (G). n = 3 for each.
(H) Cell cycle analysis of LT-HSCs from indicated mice through staining with Hoechst 33342 and Pyronin Y. Ifnar1
(I) 2 3 10 6 BM cells from mice with deficiencies in either Ifnar1 or cia-cGAS or both were co-transplanted with 2 3 10 6 WT CD45.1 BM cells into lethally irradiated CD45.1 mice, followed by cell number analysis of the indicated populations 16 weeks later. Ifnar1
Data are shown as means ± SD. *p < 0.05; **p < 0.01; ***p < 0.001. Data are representative of at least three independent experiments. See also Figure S4 .
Figure 4. Cia-cGAS Binds to cGAS
(A) Sense and antisense linearized cia-cGAS (1-400) coupled to Sepharose 4B beads were incubated with WT LSK cell lysates, followed by silver staining. Band indicated by arrow was identified to be cGAS through mass spectrometry.
(B) LSK cell lysates treated as in (A) were immunoblotted with the indicated antibodies.
(C) WT LT-HSCs were subjected to RIP with antibody against cGAS. Precipitated RNA was extracted and reversely transcribed, followed by RT-PCR analysis of indicated circular RNAs. Enrichment was normalized to IgG control of each group. (D) The indicated cells were stained with antibody against cGAS, followed by PI staining for nucleus (left). Through cellular fractionation, nuclear and cytoplasmic cGAS was calculated (right). Scale bar, 5 mm.
(E) Indicated cells were subjected to nuclear and cytoplasmic fractionation, followed by immunoblotting with the indicated antibodies. C, cytoplasm; N, nucleus. (F) In situ hybridization of circRNAs in LT-HSCs using head-to-tail probes (labeled in red). Cells were further stained with anti-cGAS antibody. Nuclei were counterstained with DAPI (left). Pearson's correlation coefficients between cGAS and circRNAs were calculated (right).
(G) Scheme for cia-cGAS mutation and substitution. The cia-cGAS (nt 52-104) region was replaced with the paired region (nt 149-197) for cia-cGAS substitution construct (Subst).
32 P-labeled linearized cia-cGAS RNAs were incubated with recombinant cGAS in the presence of anti-cGAS antibody or not, followed by EMSA assays.
(legend continued on next page) ( Figure S5H ). These data suggest that the association between cGAS and cia-cGAS depends on the secondary structure formed by the whole cia-cGAS RNA transcript. Collectively, we conclude that cia-cGAS associates with cGAS inside cells.
Cia-cGAS Inactivates the Enzymatic Activity of cGAS in LT-HSCs
We showed that cGAS was constitutively expressed in the nucleus of LT-HSCs (Figure 1) . At steady state, however, cGAS does not detect its self-genomic DNA for type I IFN induction. Therefore, we hypothesized that cia-cGAS could bind cGAS with stronger affinity than its self-genomic DNA did. To test this hypothesis, we performed competitive binding assays between linearized cia-cGAS and dsDNA. We found that increased amounts of cia-cGAS gradually restricted the binding of dsDNA with cGAS in a dose-dependent manner ( Figure 5A ). However, increased amounts of dsDNA had no such effect on the association between cia-cGAS and cGAS ( Figure 5B ). Furthermore, the strong association between cia-cGAS and cGAS was validated through RNA and DNA pulldown assays ( Figures 5C and 5D ). We next examined whether cia-cGAS impacted the cGAS synthase activity. We observed that linearized cia-cGAS abolished cGAS enzymatic activity even in the presence of dsDNA (Figure 5E ), suggesting robust inhibition of cGAS activity by ciacGAS. Consistently, cGAS was able to bind self-genomic DNA after cia-cGAS deletion ( Figures S6A-S6C ). In addition, exogenous dsDNA transfection was not detected by cGAS in the nucleus of cia-cGAS +/+ LT-HSCs ( Figure 5F ), but it was recognized by cGAS in the nucleus of cia-cGAS -/-LT-HSCs. To test whether cia-cGAS deletion induced cGAMP synthesis by cGAS, we carried out a reverse phase-HPLC assay with nuclear fractions of cia-cGAS +/+ or cia-cGAS -/-LT-HSCs. We noticed that ciacGAS -/-LT-HSC nuclear fractions displayed differential peaks from cia-cGAS +/+ counterpart ( Figure 5G ). For the predicted peak that matched cGAMP (data not shown), we conducted tandem mass spectrometry and cGAMP was virtually detected (Figure S6D ). We then transfected these peak components into bone marrow-derived macrophages (BMDMs), followed by detection of Ifnb mRNA expression. We observed that the cGAMP-contained peak could induce BMDMs to express Ifnb mRNA (Figure 5H) . Human ortholog cia-cGAS also inhibited cGAS in human HSCs ( Figures S6E and S6F) . Therefore, we conclude that ciacGAS blocks cGAS synthase activity in the nucleus through its competitive binding to genomic DNA.
Cia-cGAS Sustains Dormant HSCs via Antagonizing cGAS-Mediated Production of Type I IFNs
To physiologically determine cia-cGAS-mediated inactivation of cGAS in the maintenance of quiescent HSCs in vivo, we mutated the cGAS gene (Mb21d1) in cia-cGAS -/-LT-HSCs via a CRISPR/Cas9 approach ( Figures S7A and S7B) . We found that expression levels of type I IFNs were dramatically reduced in cia-cGAS
Mb21d1
-/-LT-HSCs ( Figure 6A ). By contrast,
cia-cGAS -/-
Mb21d1
+/+ LT-HSCs generated larger amounts of type I IFN mRNAs ( Figure 6A ). We then transplanted these cells to lethally irradiated CD45.1 recipient mice. We observed that cia-cGAS
-/-LT-HSCs could not initiate type I IFN secretion after reconstitution of the recipient BM ( Figure 6B ), whereas cia-cGAS ( Figure 6G ) and impaired self-renewal capacity of LT-HSCs after BM transplantation ( Figures 6H and 6I ).
We further verified that the interaction between cia-cGAS and cGAS was sufficient to maintain quiescent HSCs in vivo. We generated cia-cGAS overexpression lentiviruses ( Figures S7C-S7E ). We noticed that circular cia-cGAS transcripts generated by overexpression vectors failed to be digested by RNase R treatment, whereas the circular cia-cGAS transcript was not formed in the vector with mutation at the splicing site ( Figures  S7C and S7D) . We then performed rescue experiments in ciacGAS -/-LT-HSCs with these overexpression vectors, followed by transplantation assays. We found that restoration of ciacGAS fragments lacking either part of the stem regions or the mutation at the splicing site was able to produce type I IFNs akin to control virus-infected cia-cGAS -/-LT-HSCs ( Figures  S7F and S7G ), whereas restoration of full-length cia-cGAS still impaired IFN generation. Consequently, restoration of ciacGAS fragments lacking either part of the stem regions or the mutation at the splicing site did not rescue normal numbers of LT-HSCs ( Figure S7H ), while restoration of full-length cia-cGAS had such effect. In parallel, restoration of cia-cGAS fragments lacking either part of the stem regions or the mutation at the splicing site entered an active cycling state of LT-HSCs (Figure S7I) , while restoration of full-length cia-cGAS sustained in a resting state. Altogether, we conclude that cia-cGAS sustains dormant HSCs through antagonizing cGAS-mediated production of type I IFNs.
Cia-cGAS Is a Potent Suppressor of cGAS-Mediated Recognition and Autoimmune Response
We next challenged cia-cGAS +/+ and cia-cGAS -/-mice with poly(I:C). We observed that serum IFN levels were increased and a higher frequency of LT-HSCs was cycling in cia-cGAS -/-mice ( Figures 7A and 7B) . Moreover, the number of LT-HSCs in cia-cGAS -/-mice was decreased 10 days after recovery (Figure 7C) . Similar results were achieved by challenge with herpes simplex virus (HSV) virus in cia-cGAS -/-mice ( Figures 7D-7F ). In (I) 50 ng/mL linearized cia-cGAS RNAs with or without the stem regions were incubated with various amounts of cGAS (left), followed by AlphaScreen assay. Otherwise, 50 ng/mL cGAS was mixed with the indicated concentrations of biotin-labeled RNAs (right). Two-way ANOVA test was used.
(J) Point mutation scheme for DNA binding mutation of cGAS.
(K) WT cGAS and mutants were incubated with 32 P-labeled linearized cia-cGAS, followed by EMSA assay. Data are shown as means ± SD. ***p < 0.001. Data are representative of at least three independent experiments. See also Figure S5 . addition, we overexpressed cia-cGAS in macrophages and then incubated these cells with HSV. Cia-cGAS overexpression almost blocked Ifna mRNA expression ( Figure 7G ). These data suggest that cia-cGAS can exert an inhibitory function for the recognition of cGAS against invasive pathogenic DNA. The exonuclease TREX1 degrades DNA in the cytoplasm and its deficiency in humans has been linked to several autoimmune and inflammatory diseases (Crow et al., 2006; Yang et al., 2007) . Trex1-deficient mice display inflammatory diseases and premature death accompanied by elevated expression of IFN-stimulated genes (ISGs) (Gall et al., 2012) . In order to test whether cia-cGAS expression could suppress autoimmune signaling in Trex1-deficient cells, we overexpressed cia-cGAS in Trex1-deficient BMDMs ( Figure 7H ). We observed that ciacGAS overexpression could suppress Ifna mRNA expression ( Figure 7I ), suggesting that cia-cGAS could also inhibit autoimmune signaling in Trex1-deficient cells.
DISCUSSION
Adult hematopoietic stem cells (HSCs) are largely quiescent in the bone marrow niche, preserving their capacity to self renew and differentiate (Rossi et al., 2012; Wilson et al., 2008) . Disrupting the balance between self-renewal and differentiation of HSCs leads to severe pathologic consequences, such as bone marrow failure or hematologic malignancy (Essers et al., 2009; Hock et al., 2004; Zhang et al., 2006 ). Here we showed that a circular RNA cia-cGAS was highly expressed in the nucleus of LT-HSCs. Cia-cGAS was required for maintenance of dormant LT-HSC pool in the BM. Cia-cGAS deficiency in LT-HSCs caused elevated production of type I IFNs leading to exhaustion of LT-HSCs. Mechanistically, under normal conditions, cia-cGAS bound nuclear cGAS to avoid the detection of self DNA and blocked its enzymatic activity. The interaction of cia-cGAS with nuclear cGAS abrogated cGAS-mediated production of type I IFNs to sustain quiescent HSCs for blood homeostasis throughout the whole lifetime of an organism. Over the past two decades, many genes that affect HSC function have been uncovered through analyses of gene-deficient mice (Rossi et al., 2012) . As for intrinsic regulation of HSCs, various signaling players and transcription factors are involved in the modulation of HSC homeostasis. For example, transcription factor Prdm16 sustains HSC self-renewal via modulation of oxidative stress (Chuikov et al., 2010) . c-Myc conditional deletion in the hematopoietic system leads to accumulation of functionally defective HSCs (Wilson et al., 2004) . Conditional deletion of Wash causes accumulation of LT-HSCs and impairs their differentiation potential to mature blood cells . Tumor suppressor PTEN-deficient HSCs engraft normally in recipient mice but exhibit an impaired ability to maintain hematopoietic reconstitution (Zhang et al., 2006) , suggesting the dysregulation of their cell cycle and decreased retention in the BM niche. It has been reported that type I IFN signaling induces the proliferation of quiescent HSCs in the BM (Essers et al., 2009). Intrinsic IRF2-mediated regulation of type I IFN signaling is essential for the maintenance of quiescent HSCs (Sato et al., 2009 ). However, how circRNAs modulate HSC biology is still unknown. Herein we showed that the circRNA cia-cGAS was constitutively expressed in the nucleus of LT-HSCs, which inactivated the enzymatic activity of cGAS via competitive binding to cGAS, leading to maintenance of HSC pool in the BM. Our findings revealed that circRNAs also played a critical role in the regulation of HSC biology. CircRNAs are formed by covalent linkage of the ends of a single RNA molecule during the process of RNA splicing (Chen, 2016; Petkovic and M€ uller, 2015) . CircRNA species were thought to result from splicing errors, as they possess no known functions. Owing to the flexibility of RNAs and complementary sequences on RNAs, circRNAs can be composed of exon, intron, or even exon-intron sequences (Zhang et al., 2014) . Since circRNAs are resistant to RNA exonucleases, they have a quite long half-life inside the cell. Certain circRNAs have specific miRNA binding sites and act as miRNA sponges to regulate gene expression (Hansen et al., 2013; Memczak et al., 2013) . By contrast, circRNAs without obvious miRNA binding sites also have important functions. For instance, intronic circRNAs are accumulated in the nucleus that regulate gene transcription (Zhang et al., 2013) . In addition, exon-intronic circRNAs are able to interact with RNA polymerase II (Pol II) to promote the transcription of their parental genes . The cia-cGAS was an exonic circular RNA and highly expressed in the nucleus of LT-HSCs, which was involved in the regulation of HSC stemness. However, how the cia-cGAS in uniquely expressed in the nucleus of LT-HSCs among the hematopoietic system needs to be further investigated.
The cGAS synthase possesses a nucleotidyltransferase domain and two DNA binding domains . Without DNA binding, cGAS exists in an autoinhibited state (Civril et al., 2013; Gao et al., 2013b) . Binding to DNA triggers a conformational change to catalyze the product cGAMP synthesis from ATP and GTP . The second messenger cGAMP activates the adaptor STING to initiate the cGAS-STING pathway for immune responses. While the cGAS-STING pathway has evolved as a major defense mechanism against microbial infections, activation of cGAS by self DNA represents a potential threat for triggering autoimmunity (Chen et al., 2016) . Therefore, cGAS activity must be properly regulated (Chen et al., 2016; Xia et al., 2016a) . For example, cGAS can be phosphorylated by Akt to suppress cGAS enzymatic activity (Seo et al., 2015) . We recently demonstrated that cGAS is glutamylated by glutamylases TTLL4 and TTLL6 to inhibit its enzymatic activity (Xia et al., 2016b) . Removal of these glutamylations by cytosolic carboxypeptidases CCP5 and CCP6 releases the activity of cGAS. Moreover, cGAS is also sumoylated by Trim38 that sustains its stability (Hu et al., 2016) . In this study, we showed that circular RNAs also played an important role in the regulation of cGAS activation.
cGAS is activated by dsDNAs in a DNA-sequence-independent manner (Li et al., 2013a; Sun et al., 2013) . Single-stranded DNAs that can form internal duplex structures are also able to initiate cGAS enzymatic activity. Besides dsDNAs, DNA-RNA hybrids can also activate cGAS, enabling cGAS to immediately detect retroviruses during their reverse-transcription stage (Mankan et al., 2014) . However, dsRNAs are able to bind to cGAS but cannot activate it. Cia-cGAS contained a paired stem region that was able to bind to the DNA binding domains of cGAS with strong affinity. Deletion or mutation of this paired stem region ablated the binding ability to cGAS. The association of cia-cGAS with cGAS competitively inhibited the binding of cGAS to self DNA in the nucleus of LT-HSCs, which in turn blocked the activation of cGAS, leading to blockade of type I IFN production, and allowed for maintenance of quiescent HSCs in BM. Besides HSCs, we found that cia-cGAS was also expressed in several tissues, including liver, testis, thymus, brain, and colon. We showed that this mechanism of cGAS inhibition also manifested in cia-cGAS-expressing tissues. These findings suggest that the mechanism of cGAS inhibition by ciacGAS might exist in other cell types other than LT-HSCs, which needs to be further investigated.
The exonuclease TREX1 degrades DNA in the cytoplasm and its deficiency in humans has been linked to several autoimmune and inflammatory diseases (Crow et al., 2006; Yang et al., 2007) . Trex1-deficient mice display inflammatory diseases and premature death accompanied by elevated expression of IFN-stimulated genes (ISGs) (Gall et al., 2012) . A recent report showed that cGAS deletion in Trex1 À/À mice eliminates detectable pathological and molecular phenotypes (Gao et al., 2015) . We found that cia-cGAS overexpression in Trex1 À/À BMDMs was able to suppress IFN expression, suggesting that cia-cGAS might suppress autoimmune signaling in Trex1-deficient cells. Finally, cia-cGAS was an evolutionarily conserved RNA in species including humans. Therefore, cia-cGAS may apply to future treatment of hematologic malignancies or autoimmune diseases as an efficient antagonist of cGAS.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Mice
For generation of cia-cGAS deficient mice, the intronic sequence of D430042O09Rik (chr7: 125776974-125784712) was targeted by sgRNAs with the following sequences: 5 0 -TAGGTGCTCAACTCACAGACTG-3 0 and 5 0 -AAACCAGTCTGTGAGTTGAGCA-3 0 for the upstream site; 5 0 -TAGGTCCTACAGTGAGGTATGC-3 0 and 5 0 -AAACGCAT ACCTCACTGTAGGA-3 0 for the downstream site. After confirming the cleavage efficiency of these sgRNAs in mES cells, in vitro transcribed mRNAs containing the sgRNA/Cas9 sequence were injected into zygotes through microinjection, followed by implantation into surrogate mice. This model was generated by Beijing Biocytogen Co., Ltd. Mb21d1 deficient cell generation Genome editing of Mb21d1 gene was performed using the CRISPR-Cas9 system as described . GFP sequence was inserted right behind the EF1a promoter into lentivirus vector lentiCRISPRv2 to allow fluorescence sorting of infected cells. H1 promoter was reversely inserted behind the U6 promoter to allow two sgRNAs expressed by the plasmid. sgRNA against Mb21d1 exon 2: upstream, 5 0 -GAGTGTCAAGCGAACATTTC-3 0 ; downstream, 5 0 -CTTCTGGGAGCACCCACAGA-3 0 . Mouse HSCs isolated from BM were infected with lentiviruses to introduce the GFP-containing CRISPR/Cas9 vectors. After cultured in vitro for 3 days, GFP high cells were sorted through flow cytometry. Cells were analyzed through PCR analysis. PCR products were subcloned and genotyped by DNA sequencing. Genotyped cells were transplanted to recipient mice for further experiments. Since the CRISPR/ Cas9 genotyping data only provided a snapshot of the genotype of the apparently polyclonal cell population, it could not be excluded that not all alleles had been targeted by this approach. Cell culture For HSC culture, cells were cultured in StemPro-34 media (Invitrogen), containing 4 mM L-glutamine, 100 mg/ml streptomycin, 100 U/ml penicillin and the following cytokines (from PeproTech): 10 ng/ml IL-3, 25 ng/ml SCF, 25 ng/ml Ftl-3L, 10 ng/ml GM-CSF, 25 ng/ml IL-11, 4 U/ml Epo, and 25 ng/ml Tpo. For single cell culture, single LT-HSC cell was sorted into a round-bottomed 96-well plate containing StemPro-34 media supplemented with the indicated cytokines and single cell deposition was confirmed by microscopy 1 h post sorting. Cell numbers within wells were counted through light microscopy 48 h later. Bone marrow cells aspirated from mouse femurs were cultured in RPMI1640 media containing 10% FBS, 50 ng/ml MCSF for 7 days to generate bone marrow derived macrophages (BMDMs). All cells were cultured at 37 C in an incubator with 5% CO 2 . Human umbilical cord blood was obtained from the Third Hospital, Peking University (Beijing) with informed consent, according to the Institutional Review Board (IRB)-approved protocol.
FACS analysis
Mice were euthanized and bone marrow cells were flushed out from femurs in PBS buffer. Peripheral blood samples were collected through tail vein or cardiac puncture methods. Mouse spleens were dissociated into single-cell suspensions through a dissociator. Cells were sifted through 50 mm cell strainers after removing red blood cells by suspending cells in RBC lysis buffer. In respect of surface protein staining, cells suspended in PBS were incubated with fluorophore-conjugated antibodies for 2 h on ice, followed by washing with PBS for three times. Otherwise, cells were first incubated with primary antibodies for 2 h, followed by further incubation with fluorophore-conjugated secondary antibodies for 1 h. Cells were analyzed or sorted on a flow cytometer BD Aria III.
BrdU incorporation and cell cycle analysis
Mice were intraperitoneally injected with BrdU (7 mg/kg body weight) for 16 h, followed by flow cytometry of BrdU signals in LT-HSCs. For staining BrdU in the nucleus, cells were fixed and permeabilized in fixation/permeabilization buffer from the Foxp3/Transcription Factor Staining Buffer Set (eBioscience) according to manufacturer's instructions. Permeabilized cells were stained with fluorophore-conjugated anti-BrdU antibody for 2 h, followed by washing with diluted permeabilization buffer for three times. For cell cycle analysis using Hoechst/Pyronin Y staining strategy, cells were harvested and resuspended in 200 mL IMDM medium containing 10 mg/ml Hoechst33342 for 45 min at 37 C, followed by addition of Pyronin Y to a final concentration of 0.5 mg/ml for 15 min at 37 C.
RT-PCR and primers
Sorted cells were suspended in TRIzol reagent, followed by RNA extraction according to manufacturer's instructions. For circular RNA identification, total RNAs were digested with RNase R (3 U/mg) for 15 min at 37 C, followed by phenol-chloroform extraction. For canonical gene expression determination, total RNAs were used for subsequent experiments without RNase R treatment. RNAs were reverse-transcribed by random primers using Superscript II (Invitrogen), followed by RT-PCR analysis using StarScript II Two-step RT-PCR Kit (Genestar) with primers described in STAR methods. Sorted cells were subjected to genomic DNA extraction using TIANamp Genomic DNA Kit (TIANGEN Biotech, Beijing) following manufacturer's instructions. Extracted genomic DNA (gDNA) was amplified with primers specific to circular RNAs. Primer sequences were listed in the Table S1 .
Northern blot
For generation of Northern blotting probes, cia-cGAS sequence (exon5-exon6-exon4) was reversely cloned to pcDNA4 vector with a T7 promoter, followed by in vitro transcription of cia-cGAS antisense RNA post linearization of vectors using a DIG Northern Starter Kit (Roche). Total RNAs treated with or without RNase R were loaded on 2% agarose gels with 1% formaldehyde and run for 2 h in MOPS buffer. Gels were balanced in 1xTBE buffer for 30 min, followed by transferring to Hybond-N + membranes (GE Healthcare) and crosslinking by 265 nm ultraviolet with an energy of 200, 000 mJ/cm 2 . Hybridization was done at 62 C for 12 h, followed by washing in 0.1xSSC and 0.1% SDS at 62 C (30 min each) for twice, followed by anti-digoxigenin-AP incubation and visualization following manufacturer's instructions. Circular RNA sequences bound by RNA probes were listed in the Table S2 .
RNA interference
Sequences for RNA interference were designed according to pSUPER system instructions (Oligoengine). pSUPER vectors containing target sequences were constructed, and H1 promoter and target sequences were cloned and inserted to modified lentiviral vector pSIN-EF2 with multiclonal sites upstream of the EF1a promoter and GFP sequence (pSIN-EF2-GFP). Target sequences were listed in the Table S3 .
Lentivirus preparation and infection
For cia-cGAS overexpression, genomic exon regions of cia-cGAS were cloned into split GFP site on pSIN-EF2-GFP vector flanked with 1 kb cia-cGAS intron sequence (chr7: 125759133-125760301) in the upstream and 1 kb reverse-complementary sequence in the downstream. For cGAS overexpression, cGAS was either cloned to pSIN-EF2-GFP vector (for cGAS overexpression) or to lentiCRISPRv2-GFP vector (for cGAS rescue). Lentiviral vectors (pSIN-EF2-GFP or lentiCRISPRv2-GFP) were to-transfected with packaging plasmids pVSVg and psPAX2 into HEK293T cells for 48 h, followed by culture medium collection and ultracentrifugation at 25, 000 g for 1.5 h. Pellets were resuspended in IMDM medium and viral titers were determined by infecting HEK293T cells with diluted viruses. Cells were incubated with lentiviruses (MOI = 10) and centrifuged at 500 g for 2 h in the presence of 8 mg/ml polybrene.
Tween 20, 3% BSA for 20 min. Cells were counterstained with DAPI for nucleus post washing with PBS. For double FISH, cells were fixed with 4% PFA in PBS for 10 min, followed by washing with PBS for 3 times with 3 min for each. Cells were then acetylated with acetylation buffer containing 1.3% triethanolamine, 0.18% HCl, 0.25% acetic anhydride for 10 min. Cells were then washed with PBS for 3 times with 5 min for each, followed by incubation with FITC-and biotin-labeled RNA probes at 72 C overnight. Cells were washed with 0.2 x SSC for 3 times with 30 min for each at 72 C, followed by washing with buffer containing 0.1 M Tris-HCl, pH7.5, 0.15M NaCl for 5 min. Cells were then blocked with 1% blocking reagent, followed by incubation with anti-FITC-HRP for 2 h at 37 C. Cells were then washed with buffer containing 0.1 M Tris-HCl, pH7.5, 0.15M NaCl 0.05% Tween20 for 3 times with 10 min for each, followed by incubation with TSA-Plus (DNP) for 10 min. After washing with buffer containing 0.1 M Tris-HCl, pH7.5, 0.15M NaCl 0.05% Tween20 for 3 times with 5 min for each, cells were then incubated with Streptavidin-Alexa594 and anti-DNP Alexa488, followed by washing and counterstaining with DAPI for nuclear visualization. Cia-cGAS probe: 5 0 -UGUUCCAGC CUCAGCUGCACAGGGUCCUUGGCU UUCAAAUGCUUUAGUAUCCUGUGUGUGCUCCCCAGUGGCAUCCUCAUGCUUGCCAA UCACAUC-3 0 ; D430042O09Rik probe: 5 0 -UCCUUACUGUAACCCUCCUUUCUCUCC UGAGAGCAGGACCGGCUUCUCUCCACCU UCCGCAGGGCCUGACCGUCCAUCCCUAGAGGCGGCGGUUCCGG-3 0 .
DNA/RNA pulldown assay DNA/RNA pulldown assay was performed as previously described . Briefly, DNA/RNA was synthesized with NH 2 -modification at 5 0 end and the two complementary sequences were annealed, followed by coupling to CNBr-activated Sepharose 4B resin (GE Healthcare). For pulldown assays, cell lysates were incubated with DNA/RNA-linked resin in the presence of Protease Inhibitor Cocktail Set III (Calbiochem), followed by washing with buffer containing 150 mM KCl, and precipitates were analyzed by immunoblotting.
RNA immunoprecipitation (RNA-IP)
Sorted LT-HSCs were lysed in hypotonic buffer containing 10 mM HEPES, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT to remove cytoplasmic contents. Nuclear pellets were lysed in RIPA lysis buffer, followed by ten-fold dilution in RIPA wash buffer (50 mM Tris, 150 mM NaCl, 2 mM sodium pyrophosphate, 25 mM b-glycerophosphate, 1 mM EDTA, and 1 mM Na 3 VO 4 , pH 7.4). Diluted lysates were incubated with anti-cGAS antibody for 4 h post preclearance with protein A/G agarose. cGAS was then immunoprecipitated by protein A/G agarose. Immunoprecipitates were washed with RIPA wash buffer. RNA was extracted by resuspending the cGAS-RNA complex in TRIzol reagent according to manufacturer's instructions, followed by reverse transcription and RT-PCR.
Electrophoretic mobility shift assay (EMSA) 0.2 mM 32 P-labeled dsDNA or dsRNA was incubated with 1 mg purified recombinant cGAS for 30 min on ice, followed by separation on 5% native PAGE. Isotope signals were visualized by Typhoon trio+ (GE healthcare). 200-mer DNA was cloned from Actb cDNA using the following primers: sense: 5 0 -CCATCGTGGGCCGCCCTAG-3 0 ; anti-sense: 5 0 -CT CAGGGGCCACACGCAGC-3 0 . 50-mer DNA was synthesized using the following sequence: 5 0 -ATGGACTCCGGAGACGGGGTCACCCACACTGTGCCCATCTACGAGGG CTA-3 0 .
AlphaScreen
As previously described , purified cGAS variants and biotinylated RNAs were incubated at various concentrations following manufacturer's instructions (PerkinElmer).
Microarray analysis
Arraystar Mouse circRNA Array was performed as briefly described. Sorted LT-HSC and MPP cells were subjected to total RNA extraction with TRIzol reagent. Total RNAs were digested with RNase R to remove linear RNAs and enrich circular RNAs. Enriched circular RNAs were amplified and transcribed into fluorescent cRNA utilizing a random priming method (Arraystar Super RNA Labeling Kit; Arraystar). Labeled cRNAs were purified by RNeasy Mini Kit (QIAGEN). Concentrations and specific activities of the labeled cRNAs were measured by NanoDrop ND-1000. 1 mg of each labeled cRNA was fragmented by adding 5 mL 10 3 Blocking Agent and 1 mL of 25 3 Fragmentation Buffer, then heated the mixture at 60 C for 30 min, finally 25 mL 2 3 Hybridization buffer was added to dilute the labeled cRNA. 50 mL hybridization solution was dispensed into a gasket slide and assembled to a circRNA expression microarray slide. Slides were incubated for 17 hours at 65 C in an Agilent Hybridization Oven. Hybridized arrays were washed, fixed and scanned using the Agilent Scanner G2505C. Scanned images were imported into Agilent Feature Extraction software for raw data extraction. Quantile normalization of raw data and subsequent data processing were performed using the R software package. After quantile normalization of the raw data, low intensity filtering was performed, and the circRNAs that at least 1 out of 2 samples had flags in ''P'' or ''M'' (''All Targets Value'') were retained for further analyses. NimbleGen Gene Expression Profiling was performed as described below. Total RNA was extracted from cia-cGAS +/+ or cia-cGAS -/-LT-HSCs using standard RNA extraction protocol, followed by DNase incubation to remove nuclear DNA. Quality of RNA was monitored by NanoDrop ND-1000 and integrity of RNA was tested by agarose gel electrophoresis. Total RNA was subjected to labeling and array hybridization using mouse 12 3 135 K gene expression array according to manufacturer's instructions (NimbleGen). Hybridized array was scanned using the Axon GenePix 4000B microarray scanner (Molecular Devices Corporation), followed by grid alignment and expression analysis using the NimbleScan software (version 2.5). Expression data were then normalized to generate Probe level and Gene level files, followed by further analysis using the Agilent GeneSpring GX software (version 11.5.1).
QUANTIFICATION AND STATISTICAL ANALYSIS
Based on experience working with mouse-related materials and biological effect expectations, experiments were independently repeated at least three times to achieve statistical significance. A sample size of 3 to 5 mice regarding cia-cGAS deficient mice and 7 or 8 mice regarding knockdown-LT-HSC reconstituted mice was chosen for each experiment. No randomization or blinding procedures was used in this study. Data were shown as means ± SD. Data with normal distribution determined by Shapiro-Wilk normality test were statistically analyzed by two tailed Student's t tests. Unpaired t test using Welch's correction was applied regarding unequally variant data as determined by F test. Normalized data were statistically analyzed by one-sample t test. Data were analyzed in Microsoft Excel. P values were significant when p % 0.05.
DATA AND SOFTWARE AVAILABILITY
Microarray data have been deposited in the Gene Expression Omnibus (GEO) under accession numbers GSE79126 and GSE79419.
